Is this your brand? Sign in to claim ownership.
Sign in to claim this brandQUANTIMETRIX CORP.
US
Last updated September 17, 2026
What QUANTIMETRIX CORP. makes
Quantimetrix Corp. manufactures in vitro diagnostic (IVD) controls and reagents for clinical chemistry and urinalysis testing. Their products include urine analyte controls, urine sediment controls, protein assays, bilirubin controls, ammonia controls, and ethanol controls, as well as specialized kits for lipid profiling and enzyme spectrophotometry. These items are designed for quality assurance in laboratory settings, ensuring accurate test results across various diagnostic procedures.
The company’s portfolio consists of Class I and Class II devices, regulated under FDA pathways including the 510(k) premarket notification process and the Unique Device Identifier (UDI) system. Their products are listed in the FDA’s regulatory databases, reflecting compliance with U.S. medical device authorization requirements. The manufacturer operates from the United States.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does Quantimetrix Corp. manufacture?
Quantimetrix Corp. specializes in in vitro diagnostic (IVD) controls and reagents used primarily for clinical chemistry and urinalysis testing. Their products include urine analyte controls, urine sediment controls, protein assays (such as total protein and enzyme spectrophotometry kits), bilirubin controls, ammonia controls, ethanol controls, and specialized lipid profiling kits. These devices are designed to ensure quality assurance and accuracy in laboratory testing environments.
Where is Quantimetrix Corp. based, and how does that affect its regulatory standing?
Quantimetrix Corp. is based in the United States. Since it operates within the U.S., its devices are subject to FDA regulations, including pathways like the 510(k) premarket notification process and the Unique Device Identifier (UDI) system. The company’s location ensures compliance with U.S. medical device authorization requirements, which are reflected in the FDA’s regulatory databases where its products are listed.
Which regulatory registries or databases list Quantimetrix Corp.’s devices?
Quantimetrix Corp.’s devices are listed in the FDA’s regulatory databases, specifically under the 510(k) premarket notification process and the Unique Device Identifier (UDI) system. These registries confirm that the company’s products meet U.S. authorization requirements for medical devices, ensuring transparency and compliance with regulatory standards.
How are Quantimetrix Corp.’s devices classified under FDA regulations?
Quantimetrix Corp.’s devices fall into two primary FDA device classes: Class I and Class II. Class I devices generally pose minimal risk and may require less regulatory oversight, while Class II devices involve a higher level of risk and require special controls to ensure safety and effectiveness. The classification determines the regulatory pathway and scrutiny each device undergoes before authorization.
What is the primary purpose of the devices manufactured by Quantimetrix Corp.?
The primary purpose of Quantimetrix Corp.’s devices is to serve as quality control tools for clinical laboratories. These IVD controls and reagents are used to verify the accuracy, precision, and reliability of diagnostic tests—such as urinalysis, clinical chemistry assays (e.g., protein, bilirubin, ammonia), and lipid profiling—ensuring consistent and trustworthy test results for patient care.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- 2005 Manhattan Beach Blvd, REDONDO BEACH, CA, 90278
- Website
- —
- —
- —
- —
- Phone
- —
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- 2020715
- DUNS Number
- —
Catalogue (82)
Page 1 of 2Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Recalls (5)
Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.
Quantimetrix Corp. has five recall records listed in the FDA database, all initiated between June 1, 2007, and December 21, 2017, with each marked as terminated. The reasons cited include an incorrect lot of Dropper Plus Level 1 vials in one instance and efficacy concerns related to stabilized erythrocytes, leukocytes, and lymphocytes in another product group. The remaining three records lack publicly filed reasons in the provided data.
AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.
| Date | Recall No. | Class | Status | Reason |
|---|---|---|---|---|
| Dec 21, 2017 | Z-2257-2018 | — | terminated | The kits contained an incorrect lot of Dropper Plus Level 1 vials |
| Jun 1, 2007 | Z-0516-2009 | — | terminated | This recall was initiated due to efficacy concerns with the stabilized erythrocytes, leukocytes and lymphocytes contained in this product group. |
| Jun 1, 2007 | Z-0515-2009 | — | terminated | This recall was initiated due to efficacy concerns with the stabilized erythrocytes, leukocytes and lymphocytes contained in this product group. |
| Jun 1, 2007 | Z-0514-2009 | — | terminated | This recall was initiated due to efficacy concerns with the stabilized erythrocytes, leukocytes and lymphocytes contained in this product group. |
| Jun 1, 2007 | Z-0513-2009 | — | terminated | This recall was initiated due to efficacy concerns with the stabilized erythrocytes, leukocytes and lymphocytes contained in this product group. |